PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:40 AM ET

Sponsor Check › Person

GS
No photo found yet (own website and image search run after this page is viewed)

Gary Schuman

Named as an officer, director or promoter on SEC Form D filings · CA, MA, WA · Jun 19, 2015 → Jun 19, 2015

2deals (issuers)
$73.1Mreported sold
159investors
5Form D filings
2015year on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:33 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Gary Schuman is listed as an executive officer and director on 5 SEC Form D filings by 2 issuers between Jun 2015 and Mar 2017: Cue Biopharma, Inc. (Boston, MA — biotechnology — 2015–2016; $50M reported sold to 133 investors) and theMaven, Inc. (New York, NY — other technology — 2017; $23.1M reported sold to 26 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director, over about 2 years. Across those companies the filings report $73.1M sold in total.

Listed alongside Christopher Marlett (5 shared filings), Amy Wang (4 shared filings), Anthony DiGiandomenico (4 shared filings), Cameron Gray (4 shared filings), RODOLFO CHAPARRO (4 shared filings) and 12 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gary. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 5 public filings for Gary Schuman and found 8 differences, 2 worth asking the sponsor about: 9 bankruptcy cases name the subject or team members; Amount sold went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Gary Schuman has not run yet — it is joining a line of 25,323 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:33 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Gary Schuman..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Gary F. Schuman and Sandra K. Schuman closed
United States Bankruptcy Court, W.D. New York · No. 1-10-12979 · Filed Jul 8, 2010 · Closed Sep 22, 2014
Role of Gary F. Schuman and Sandra K. Schuman: Debtor · Outcome: Case closed 2014-09-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); court in the person's filing state (NY)
Gary G. Schuman and Kay E. Schuman closed
United States Bankruptcy Court, E.D. California · No. 10-17410 · Filed Jun 30, 2010 · Closed Oct 15, 2010
Role of Gary G. Schuman and Kay E. Schuman: Debtor · Outcome: Case closed 2010-10-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); court in the person's filing state (CA)
Gary W. Schuman closed
United States Bankruptcy Court, M.D. Florida · No. 8:05-bk-05801 · Filed Mar 30, 2005 · Closed Jul 12, 2005
Role of Gary W. Schuman: Debtor · Outcome: Case closed 2005-07-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); court in FL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:33 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

8 differences found between the filings for Gary Schuman — 2 worth asking about (compared 5 filings on Oct 24, 2026)

Worth asking · Jun 11, 1992 – Jul 21, 2025

9 bankruptcy cases name the subject or team members

Bankruptcy case: Gary F. Schuman and Sandra K. Schuman — filed Jul 8, 2010 · Bankruptcy case: Gary G. Schuman and Kay E. Schuman — filed Jun 30, 2010 · Bankruptcy case: Gary W. Schuman — filed Mar 30, 2005 · Bankruptcy case: Jose Enrique Ramirez and Marlett Ramirez — filed Jul 21, 2025 · Bankruptcy case: Anthony P. Digiandomenico — filed Mar 31, 2011 · and 4 more

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, W.D. New York ↗Docket · United States Bankruptcy Court, E.D. California ↗Docket · United States Bankruptcy Court, M.D. Florida ↗Docket · United States Bankruptcy Court, C.D. California ↗
Sources
Worth asking · Dec 22, 2016 – Dec 30, 2016

Amount sold went down between filings — Cue Biopharma, Inc.

The Dec 22, 2016 filing says $20,000,000 sold; the Dec 30, 2016 Form D/A says $16,414,900 sold — $3,585,100 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Dec 22, 2016 ↗Form D/A (later) · Dec 30, 2016 ↗Cue Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Mar 9, 2017 – Mar 17, 2017

No amendment in the last 12 months on an offering that may still be open — theMaven, Inc. (latest filing Mar 17, 2017)

The latest filing for this offering is dated Mar 17, 2017 (first sale Mar 9, 2017). It reports $500,000 sold of $5,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Mar 17, 2017 ↗theMaven, Inc. — PartnerFacts page ↗
Sources
Note · Jun 15, 2015 – Jun 19, 2015

No amendment in the last 12 months on an offering that may still be open — Cue Biopharma, Inc. (latest filing Jun 19, 2015)

The latest filing for this offering is dated Jun 19, 2015 (first sale Jun 15, 2015). It reports $0 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Jun 19, 2015 ↗Cue Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Jun 19, 2015 – Dec 22, 2016

Gary Schuman's role changed at Cue Biopharma, Inc.: executive officer, director → executive officer

The Jun 19, 2015 filing lists Gary Schuman as executive officer, director; the Dec 22, 2016 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jun 19, 2015 ↗Form D · Dec 22, 2016 ↗Gary Schuman — PartnerFacts page ↗Cue Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Dec 22, 2016 – Dec 30, 2016

Offering amount lowered between filings — Cue Biopharma, Inc.

The Dec 22, 2016 filing says $20,000,000 offered; the Dec 30, 2016 Form D/A says $16,414,900.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Dec 22, 2016 ↗Form D/A (later) · Dec 30, 2016 ↗Cue Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Jun 19, 2015 – Dec 22, 2016

Address moved from Santa Monica, CA to Cambridge, MA — Cue Biopharma, Inc.

The people listed on the Jun 19, 2015 filing give Santa Monica, CA; on the Dec 22, 2016 filing they give Cambridge, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jun 19, 2015 ↗Form D · Dec 22, 2016 ↗Cue Biopharma, Inc. — PartnerFacts page ↗
Sources
Note · Jun 19, 2015 – Mar 17, 2017

Gary Schuman is listed with 3 different address states: CA, MA, WA

CA on 2 filings (Jun 19, 2015 to Jun 19, 2015); MA on 2 filings (Dec 22, 2016 to Dec 30, 2016); WA on 1 filing (Mar 17, 2017).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jun 19, 2015 ↗Form D · Dec 22, 2016 ↗Form D · Mar 17, 2017 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

3 of 4 offerings report sales commissions totalling $2,570,745; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 17, 2017 D
theMaven, Inc.
File 021-282799
$250,000 (est.)$0$0
Proceeds will be used for general working capital purposes
MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
Dec 30, 2016 D/A
Cue Biopharma, Inc.
File 021-276931
$1,320,745$0$0MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
Jun 19, 2015 D
Cue Biopharma, Inc.
File 021-242130
$1,000,000 (est.)$0$0MDB Capital Group, LLC BrokerCheck CRD 42677 ↗EDGAR ↗
Jun 19, 2015 D
Cue Biopharma, Inc.
File 021-242131
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Gary Schuman on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

T
Other Technology

theMaven, Inc.

New York, NY · Mar 17, 2017
  • Mar 17, 2017 · D · $500,000 sold of $5,000,000 · 1 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $23.1M from 26 investors (100% of the $5M target) as of the latest filing. Gary is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CB
Biotechnology

Cue Biopharma, Inc.

Boston, MA · Jun 19, 2015 → Dec 30, 2016 · 4 filings
  • Dec 30, 2016 · D/A · $16,414,900 sold of $16,414,900 · 133 investors · min. No minimum reported · role: Executive Officer (Chief Financial Officer) EDGAR ↗
  • Dec 22, 2016 · D · $20,000,000 sold of $20,000,000 · 133 investors · min. No minimum reported · role: Executive Officer (Chief Financial Officer) EDGAR ↗
  • Jun 19, 2015 · D · $0 sold of $1,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director (Chief Financial Officer) EDGAR ↗
  • Jun 19, 2015 · D · $10,000,000 sold of $10,000,000 · 121 investors · min. No minimum reported · role: Executive Officer, Director (Chief Financial Officer) EDGAR ↗

Raised $50M from 133 investors (100% of the $16.4M target) as of the latest filing. Gary is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Gary 17

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Marlett

Director · 5 shared filings (2 issuers) · also on 3 other issuers

Christopher Marlett is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Wang

Executive Officer, Director · 4 shared filings (1 issuer) · also on 4 other issuers

Amy Wang is on 5 issuers in total — a repeat sponsor. Their page lists every one.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Cameron Gray

Executive Officer, Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Gary Schuman. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony DiGiandomenico

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Gary Schuman. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

RODOLFO CHAPARRO

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Schuman. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald D. Seidel, III

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Schuman. Their page shows their other deals.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel R. Passeri

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Schuman. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Almo

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Gary Schuman. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

STEVEN MCKNIGHT

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gary Schuman. Their page shows their other deals.

PK
No photo found yet (own website and image search run after this page is viewed)
Person

PETER KIENER

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Schuman. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

BARRY SIMON

Director · 2 shared filings (1 issuer)

Listed on the same filings as Gary Schuman. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James Heckman

Executive Officer, Director · 1 shared filing (1 issuer) · also on 5 other issuers

James Heckman is on 6 issuers in total — a repeat sponsor. Their page lists every one.

PM
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Mills

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Schuman. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Levande

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Schuman. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Sornsin

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Gary Schuman. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Ross Levinson

Director · 1 shared filing (1 issuer)

Listed on the same filings as Gary Schuman. Their page shows their other deals.

BJ
No photo found yet (own website and image search run after this page is viewed)
Person

Benjamin Joldersma

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Gary Schuman. Their page shows their other deals.

The team behind the deals

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Gary Schuman by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Gary Schuman is listed on, as found in their SEC filings (Form C, Reg A, Form ADV, EDGAR profile) or on the sponsor's own site; none belongs to the person unless the sponsor's site says so. Checked Oct 24, 2026.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Found on the sponsor's own site

cuebiopharma.com ↗ found on Cue Biopharma, Inc. (cuebiopharma.com — domain named after the issuer; homepage names "Cue Biopharma") x — x — found on cuebiopharma.com ↗ found on Cue Biopharma, Inc. linkedin — linkedin — found on cuebiopharma.com ↗ found on Cue Biopharma, Inc.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Massachusetts MassCourts ↗Washington Courts case search (dw.courts.wa.gov) ↗New York WebCivil Supreme ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Massachusetts Secretary of State business search ↗Washington Secretary of State business search ↗New York Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Gary Schuman appears on a new Form D, or when a court case or SEC action is matched to them. See plans →